Co-op: Pharmaceutical Development

Biogen
0 reviews

Posted on: 30 Jan 2021

Cambridge, MA

Apply on Company site Save this job

Job Description

Job Description

We are seeking a highly motivated and creative individual to take the full-time co-op role in the Pharmaceutical Development team. The co-op position provides an exciting opportunity to gain hands-on laboratory experience and exposure to pharmaceutical development, characterization, and imaging analysis. The project focuses on implementing X-ray Micro-computed Tomography and Quantitative Image Processing technology for oral tablets characterization and investigate the feasibility of assessing the key properties of film coating and their correlation to drug product dissolution performance.

Position Description

Key Responsibilities:

* Characterize the functional film coating of oral tablets formulation by utilizing Micro-CT technology.
* Conduct quantitative imaging processing and analysis of oral dosage form. Improve the quality of imaging by optimizing imaging process and method.
* Document laboratory experiments.
* Assist in experiment design, data analysis, and trouble shooting.
* Candidates must be strong team players and have an ability to collaborate effectively on complex projects.

Qualifications

To participate in the Biogen Co-op Program, students must meet the following eligibility criteria:

* Legal authorization to work in the U.S.
* Grade point average of 3.2 or higher preferred.
* At least 18 years of age prior to the scheduled start date.
* Be currently enrolled in an accredited college or university.

Additional qualifications:

* Experience on pharmaceutical science, analytical characterization, imaging technology and relevant analysis software is preferred.
* Candidate should be able to work independently as well as have excellent communication/teamwork skills. Good problem-solving ability and creativity.

Education

* Desired majors include: Pharmaceutical Sciences, Chemical Engineering, Bioengineering, Chemistry, Computer Science, or related field.

Additional Information

All your information will be kept confidential according to EEO guidelines.

Biogen

Cambridge, MA

Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases worldwide. The company offers TECFIDERA, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for the treatment of multiple sclerosis (MS); SPINRAZA for the treatment of spinal muscular atrophy; and FUMADERM for the treatment of plaque psoriasis. It also provides BENEPALI, an etanercept biosimilar referencing ENBREL; FLIXABI, an infliximab biosimilar referencing REMICADE; and IMRALDI, an adalimumab biosimilar referencing HUMIRA. In addition, the company offers RITUXAN for the treatment of non-Hodgkin's lymphoma, chronic lymphocytic leukemia (CLL), rheumatoid arthritis, two forms of ANCA-associated vasculitis, and pemphigus vulgaris; RITUXAN HYCELA for non-Hodgkin's lymphoma and CLL; GAZYVA to treat CLL and follicular lymphoma; and OCREVUS for the treatment of primary progressive MS and relapsing MS, and other anti-CD20 therapies.

Further, it is involved in developing BIIB098, Opicinumab, and BIIB061 for MS and neuroimmunology; Aducanumab, Elenbecestat, BAN2401, BIIB092, BIIB076, and BIIB080 to treat Alzheimer's disease and dementia; BIIB092 and BIIB054 for treating Parkinson's disease and movement disorders; BIIB067, BIIB078, and BIIB110 to treat neuromuscular disorders; BIIB093, TMS-007, and Natalizumab to treat acute neurology; BIIB104 for treating neurocognitive disorders; BIIB074 and BIIB095 for pain; and Dapirolzumab pegol, BG00011, and BIIB059 for treating other diseases, which are under various stages of development.

The company offers products through its sales force and marketing groups. Biogen Inc. has collaboration agreements with Genentech, Inc., Eisai Co., Ltd., Alkermes Pharma Ireland Limited, Bristol-Myers Squibb Company, Acorda Therapeutics, Inc., AbbVie Inc., C4 Therapeutics, University of Pennsylvania, Applied Genetic Technologies Corporation, and others. The company was founded in 1978 and is headquartered in Cambridge, Massachusetts.